VIRTUS HEALTH LIMITED (VRT)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

VRT - VIRTUS HEALTH LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$8.12

20 May
2022

0.000

OPEN

$8.11

0.000

HIGH

$8.13

136,099

LOW

$8.11

TARGET
$7.333 -9.7% downside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
EBO . SLA . CAJ . GXL . HSO . MPL . MVF . NHF . HLS . RHC . SHL . MDR . M7T . HLA . PSQ . SIL . PKS . ONT . DOC . BMT . NVL . AHX . ALC . ACL .
FNARENA'S MARKET CONSENSUS FORECASTS
VRT: 1
Title FY20
Actual
FY21
Actual
FY22
Forecast
FY23
Forecast
EPS (cps) xxx 53.9 37.5 xxx
DPS (cps) xxx 24.0 25.3 xxx
EPS Growth xxx 100.0% - 30.4% xxx
DPS Growth xxx 100.0% 5.4% xxx
PE Ratio xxx N/A 21.7 xxx
Dividend Yield xxx N/A 3.1% xxx
Div Pay Ratio(%) xxx 44.6% 67.5% xxx

Dividend yield today if purchased 3 years ago: 6.08%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

2.96

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 23/03 - ex-div 12c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title 201620172018201920202021
EPS Basic xxxxxxxxxxxxxxx53.9
DPS All xxxxxxxxxxxxxxx24.0
Sales/Revenue xxxxxxxxxxxxxxx322.9 M
Book Value Per Share xxxxxxxxxxxxxxx373.3
Net Operating Cash Flow xxxxxxxxxxxxxxx66.6 M
Net Profit Margin xxxxxxxxxxxxxxx13.36 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201620172018201920202021
Return on Capital Employed xxxxxxxxxxxxxxx15.23 %
Return on Invested Capital xxxxxxxxxxxxxxx8.30 %
Return on Assets xxxxxxxxxxxxxxx7.00 %
Return on Equity xxxxxxxxxxxxxxx15.23 %
Return on Total Capital xxxxxxxxxxxxxxx10.74 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx32.5 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

-0.3

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

23/02/2022

3

Downgrade to Neutral from Outperform

$7.35

-9.48%

First half net profit was -12% below Macquarie's forecasts. This reflects weaker revenue and higher costs. Nevertheless, the broker considers this reflects an investment in future growth and the market should continue to benefit from behavioural shifts.

That said, Macquarie believes growth is captured in current forecasts and downgrades to Neutral from Outperform. Target is raised to $7.35 from $7.10, stemming from an equal weighting of DCF valuations and the CapVest bid at $7.60.

FORECAST
Macquarie forecasts a full year FY22 dividend of 19.70 cents and EPS of 35.40 cents.
Macquarie forecasts a full year FY23 dividend of 26.30 cents and EPS of 43.80 cents.

Morgan Stanley

xx/xx/xxxx

5

xxxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

VRT STOCK CHART